Withdrawal of intravenous glyceryl trinitrate: Absence of rebound phenomena with transition to oral isosorbide dinitrate

Clinical and Experimental Pharmacology and Physiology

Volumn 32, Issue 4, 2005, Pages 269-272

  Kelly, Elizabeth A ^a   Ahmed, Rebekah M ^a   Horowitz, John D ^a,b  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b QUEEN ELIZABETH HOSPITAL   (Australia)

Author keywords

Augmentation index; Glyceryl trinitrate; Rebound

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLYCERYL TRINITRATE; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ISOSORBIDE DINITRATE;

ACUTE HEART INFARCTION; ADULT; AGED; ARTERY COMPLIANCE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG INFUSION; DRUG TOLERANCE; DRUG WITHDRAWAL; FEMALE; HEART MUSCLE ISCHEMIA; HEMODYNAMICS; HUMAN; HYPOTENSION; MALE; REBOUND; TREATMENT OUTCOME; UNSTABLE ANGINA PECTORIS; VASODILATATION; VASOMOTOR REFLEX; WITHDRAWAL REFLEX;

ADMINISTRATION, ORAL; AGED; ANGINA PECTORIS; ANGINA, UNSTABLE; COHORT STUDIES; CORONARY DISEASE; CORONARY VESSELS; DRUG TOLERANCE; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; ISOSORBIDE DINITRATE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NITROGLYCERIN; VASOCONSTRICTION; VASODILATOR AGENTS;

EID: 17844381830     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2005.04182.x     Document Type: Article

References (28)

1. Theroux P, Willerson JT, Armstrong PW. Progress in the treatment of acute coronary syndromes: A 50-year perspective (1950-2000). Circulation 2000; 102: IV2-13.
2. Mikolich JR, Nicoloff NB, Robinson PH, Logue RB. Relief of refractory angina with continuous intravenous infusion of nitroglycerin. Chest 1980; 77: 375-9.
3. Sage PR, de la Lande IS, Stafford I et al. Nitroglycerin tolerance in human vessels: Evidence for impaired nitroglycerin bioconversion. Circulation 2000; 102: 2810-15.
4. Jugdutt BI, Warnica JW. Intravenous nitroglycerin therapy to limit myocardial infarct size, expansion, and complications. Effect of timing, dosage, and infarct location. Circulation 1988; 78: 906-19.
5. Horowitz JD. Role of nitrates in unstable angina pectoris. Am. J. Cardiol. 1992; 70: 64B-71B.
6. Thadani U. Nitrate tolerance, rebound, and their clinical relevance in stable angina pectoris, unstable angina, and heart failure. Cardiovasc. Drugs Ther. 1997; 10: 735-42.
7. Arstall MA, Yang J, Stafford I, Betts WH, Horowitz JD. N-acetylcysteine in combination with nitroglycerin and streptokinase for the treatment of evolving acute myocardial infarction. Safety and biochemical effects. Circulation 1995; 92: 2855-62.
8. Beltrame JF, Stewart S, Leslie S, Poropat S, Horowitz JD. Resolution of ST-segment elevation following intravenous administration of nitroglycerin and verapamil. Am. J. Cardiol. 2002; 89: 452-5.
9. Horowitz JD, Henry PJ. Recent developments in nitrate therapy of ischaemic heart disease. Med. J. Aust. 1987; 146: 93-6.
10. Pepine CJ, Lopez LM, Bell DM, Handberg-Thurmond EM, Marks RG, McGorray S. Effects of intermittent transdermal nitroglycerin on occurrence of ischemia after patch removal: Results of the second transdermal intermittent dosing evaluation study (TIDES-II). J. Am. Coll. Cardiol. 1997; 30: 955-61.
11. Hebert D, Lam JY. Nitroglycerin rebound associated with vascular, rather than platelet, hypersensitivity. J. Am. Coll. Cardiol. 2000; 36: 2311-16.
12. Ben-David A. Cardiac arrest in an explosives factory worker due to withdrawal from nitroglycerin exposure. Am. J. Ind. Med. 1989; 15: 719-22.
13. Lund RP, Haggendal J, Johnsson G. Withdrawal symptoms in workers exposed to nitroglycerine. Br. J. Ind. Med. 1968; 25: 136-8.
14. Figueras J, Lidon R, Cortadellas J. Rebound myocardial ischaemia following abrupt interruption of intravenous nitroglycerin infusion in patients with unstable angina at rest. Eur. Heart J. 1991; 12: 405-11.
15. DeMots H, Classer SP. Intermittent transdermal nitroglycerin therapy in the treatment of chronic stable angina. J. Am. Coll. Cardiol. 1989; 13: 786-95.
16. Ferratini M, Pirelli S, Merlini P, Silva P, Pollavini G. Intermittent transdermal nitroglycerin monotherapy in stable exercise-induced angina: A comparison with a continuous schedule. Eur. Heart J. 1989; 10: 998-1002.
17. Freedman SB, Daxini BV, Noyce D, Kelly DT. Intermittent transdermal nitrates do not improve ischemia in patients taking beta-blockers or calcium antagonists: Potential role of rebound ischemia during the nitrate-free period. J. Am. Coll. Cardiol. 1995; 25: 349-55.
18. Lin SG, Flaherty JT. Crossover from intravenous to transdermal nitroglycerin therapy in unstable angina pectoris. Am. J. Cardiol. 1985; 56: 742-8.
19. Horowitz JD, Antman EM, Lorell BH, Barry WH, Smith TW. Potentiation of the cardiovascular effects of nitroglycerin by N-acetylcysteine. Circulation 1983; 68: 1247-53.
20. Winniford MD, Kennedy PL, Wells PJ, Hillis LD. Potentiation of nitroglycerin-induced coronary dilatation by N-acetylcysteine. Circulation 1986; 73: 138-42.
21. Karamanoglu M, O'Rourke M, Avolio A, Kelly R. An analysis of the relationship between central aortic and peripheral upper limb pressure waves in man. Eur. Heart J. 1993; 14: 160-7.
22. Segers P, Qasem A, De Backer T, Carlier S, Verdonck P, Avolio A. Peripheral 'oscillatory' compliance is associated with aortic augmentation index. Hypertension 2001; 37: 1434-9.
23. Vlachopoulos C, Hirata K, O'Rourke MF. Pressure-altering agents affect central aortic pressures more than is apparent from upper limb measurements in hypertensive patients: The role of arterial wave reflections. Hypertension 2001; 38: 1456-60.
24. Cohn JN, Archibald DG, Ziesche S et al. Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study. N. Engl. J. Med. 1986; 314: 1547-52.
25. O'Rourke M. Arterial stiffness, systolic blood pressure, and logical treatment of arterial hypertension. Hypertension 1990; 15: 339-47.
26. Parker JO, Vankoughnett KA, Farrell B. Comparison of buccal nitroglycerin and oral isosorbide dinitrate for nitrate tolerance in stable angina pectoris. Am. J. Cardiol. 1985; 56: 724-8.
27. Parker JO, Farrell B, Lahey KA, Moe G. Effect of intervals between doses on the development of tolerance to isosorbide dinitrate. N. Engl. J. Med. 1987; 316: 1440-4.
28. Kelly RP, Gibbs HH, O'Rourke MF et al. Nitroglycerin has more favourable effects on left ventricular afterload than apparent from measurement of pressure in a peripheral artery. Eur. Heart J. 1990; 11: 138-44.